These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6296191)

  • 1. Failure of angiotensin II to stimulate increases in concentrations of adrenal androgens, 17-hydroxyprogesterone, or adrenocorticotropin in congenital 21-hydroxylase deficiency.
    Wisgerhof M; Mellinger RC; Zafar MS
    J Clin Endocrinol Metab; 1983 Mar; 56(3):627-31. PubMed ID: 6296191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin and adrenal steroidogenesis: study of 21-hydroxylase-deficient congenital adrenal hyperplasia.
    Schaison G; Couzinet B; Gourmelen M; Elkik F; Bougneres P
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1390-4. PubMed ID: 7002950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Partial deficiency in 21-hydroxylase in certain forms of hirsutism].
    Lucisano A; Satta MA; Tripodi R; Mobili L; De Cicco F; Monaco F; Dell'Acqua S; Roche J
    C R Seances Soc Biol Fil; 1989; 183(2):117-21. PubMed ID: 2555033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternate day prednisone therapy in congenital adrenal hyperplasia: adrenal androgen suppression and normal growth.
    Linder B; Feuillan P; Chrousos GP
    J Clin Endocrinol Metab; 1989 Jul; 69(1):191-5. PubMed ID: 2543690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
    Charmandari E; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
    Feuillan P; Pang S; Schürmeyer T; Avgerinos PC; Chrousos GP
    J Clin Endocrinol Metab; 1988 Jul; 67(1):154-60. PubMed ID: 2837498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone preparation does not alter corticoid and androgen responses to adrenocorticotropin.
    Rosenfield RL; Helke J; Lucky AW
    J Clin Endocrinol Metab; 1985 Mar; 60(3):585-9. PubMed ID: 2982902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary-adrenal responses to corticotropin-releasing factor in late onset 21-hydroxylase deficiency.
    Carmina E; Lobo RA
    Fertil Steril; 1990 Jul; 54(1):79-83. PubMed ID: 2162789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of long acting glucocorticoids on menstrual abnormalities in patients with virilizing congenital adrenal hyperplasia.
    Richards GE; Grumbach MM; Kaplan SL; Conte FA
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1208-15. PubMed ID: 233693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasmatic 17-alpha-hydroxyprogesterone in congenital adrenal hyperplasia due to 21 hydroxylase deficiency, treated and untreated].
    Loras B; Roux H; Audi-Parera L; David M; Bertrand J
    Biomedicine; 1974 Jul; 21(7):317-22. PubMed ID: 4373095
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of late-onset 21-hydroxylase deficiency congenital adrenal hyperplasia in adolescents.
    Emans SJ; Grace E; Fleischnick E; Mansfield MJ; Crigler JF
    Pediatrics; 1983 Nov; 72(5):690-5. PubMed ID: 6314235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adrenal hyperplasia as a result of 21-hydroxylase deficiency: prenatal diagnosis and treatment. Neonatal diagnosis].
    Lambotte C
    Rev Med Liege; 1986 Jan; 41(2):37-44. PubMed ID: 3006204
    [No Abstract]   [Full Text] [Related]  

  • 13. 21-Hydroxylase deficiency in female hyperandrogenism: screening and diagnosis.
    Azziz R; Zacur HA
    J Clin Endocrinol Metab; 1989 Sep; 69(3):577-84. PubMed ID: 2547827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of plasma ACTH concentration by angiotensin II infusion in normal humans and in a subject with a steroid 17 alpha-hydroxylase defect.
    Semple PF; Buckingham JC; Mason PA; Fraser R
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):137-44. PubMed ID: 218750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma 21-deoxycorticosterone (21-DB) levels in late-onset adrenal 21-hydroxylase deficiency suggest a mild defect of the mineralocorticoid pathway.
    Fiet J; Gueux B; Raux-DeMay MC; Kuttenn F; Vexiau P; Brerault JL; Couillin P; Galons H; Villette JM; Julien R
    J Clin Endocrinol Metab; 1989 Mar; 68(3):542-7. PubMed ID: 2537337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Pang SY; Pollack MS; Marshall RN; Immken L
    N Engl J Med; 1990 Jan; 322(2):111-5. PubMed ID: 2403652
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening for late onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Khandekar S; Lata V; Dash RJ
    Indian J Med Res; 1990 Apr; 92():79-82. PubMed ID: 2164496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New studies of the 11 beta-hydroxylase and 18-hydroxylase enzymes in the hypertensive form of congenital adrenal hyperplasia.
    Levine LS; Rauh W; Gottesdiener K; Chow D; Gunczler P; Rapaport R; Pang S; Schneider B; New MI
    J Clin Endocrinol Metab; 1980 Feb; 50(2):258-63. PubMed ID: 6243663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 17-Hydroxyprogesterone responses to adrenocorticotropin in children with premature adrenarche.
    Granoff AB; Chasalow FI; Blethen SL
    J Clin Endocrinol Metab; 1985 Mar; 60(3):409-15. PubMed ID: 2982895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal gestation and diminished androgen responsiveness in an untreated patient with 21-hydroxylase deficiency.
    Leichter SB; Jacobs LS
    J Clin Endocrinol Metab; 1976 Mar; 42(3):575-82. PubMed ID: 176172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.